|  | Year Ended December 31, 2018 (Unaudited) | Year Ended December 31, 2017 (Audited) | Year Ended December 31, 2016 (Audited) | 
	  
	    |  | (in thousands) | 
	  
	    | Cash flows from operating    activities: | 
	  
	    | Net income attributable to Ebix, Inc. | $93,139 | 100,618 | 93,847 | 
	  
	    | Net income (loss) attributable to    noncontrolling interest | (58) | 1,965 | 447 | 
	  
	    | Adjustments    to reconcile net income to cash provided by operating activities: | 
	  
	    | Depreciation and amortization | 11,292 | 11,123 | 10,746 | 
	  
	    | Provision for doubtful accounts | 3,571 | 1,713 | 1,515 | 
	  
	    | Provision for deferred taxes, net of    acquisitions and effects of currency translation | (13,043) | (13,667) | (6,410) | 
	  
	    | Unrealized foreign exchange losses | 606 | 1,387 | 32 | 
	  
	    | Gain on investment interest in IHC/Ebix    joint venture | — | — | (1,162 | 
	  
	    | Amortization of capitalized software    development costs | 2,233 | 2,175 | 1,116 | 
	  
	    | Share-based compensation | 2,811 | 2,818 | 2,794 | 
	  
	    | Reduction of acquisition earn-out    contingent liability | (1,391) | (164) | (1,344) | 
	  
	    | Reduction of rent expense as a result of    purchase accounting adjustment | — | (948) | — | 
	  
	    | Changes    in current assets and liabilities, net of acquisitions: |  |  |  | 
	  
	    | Accounts receivable | (10,810) | (34,245) | (12,659) | 
	  
	    | Other assets | (8,486) | (2,133) | 1,789 | 
	  
	    | Accounts payable and accrued expenses | 6,539 | 8,906 | (3,703) | 
	  
	    | Accrued payroll and related benefits | (788) | (3,979) | 170 | 
	  
	    | Deferred rent | (360) | (413) | (234) | 
	  
	    | Reserve for potential uncertain income    tax return positions | 149 | 5,879 | 490 | 
	  
	    | Other liabilities | 13,205 | 252 | (3,039) | 
	  
	    | Deferred revenue | (8,740) | (4,480) | 2,176 | 
	  
	    | Net    cash provided by operating activities | 89,869 | 76,807 | 86,571 | 
	  
	    | Cash    flows from investing activities: |  |  |  | 
	  
	    | Investment in Transcorp, net of cash    acquired | (6,554) | — | — | 
	  
	    | Investment in Centrum, net of cash    acquired | (176,137) | — | — | 
	  
	    | Investment in SmartClass, net of cash    acquired | (7,593) | — | — | 
	  
	    | Cash received from Paul Merchants for    10% stake in MTSS | 4,996 | — | — | 
	  
	    | Investment in Indus, net of cash    acquired | (24,261) | — | — | 
	  
	    | Investment in Mercury, net of cash    acquired | (11,356) | — | — | 
	  
	    | Investment in Miles, net of cash    acquired | (17,721) | — | — | 
	  
	    | Investment in Leisure, net of cash    acquired | (1,304) | — | — | 
	  
	    | Investment in AHA Taxis, net of cash    acquired | (71) | — | — | 
	  
	    | Investment in Routier, net of cash    acquired | (413) | — | — | 
	  
	    | Investment in Weizmann, net of cash    acquired | 12,886 | — | — | 
	  
	    | Investment in Lawson, net of cash    acquired | 381 | — | — | 
	  
	    | Investment in Business Travels, net of    cash acquired | (414) | — | — | 
	  
	    | Payment of acquisition earn-out    contingency, ItzCash | (3,831) | — | — | 
	  
	    | Investment in Paul Merchants | — | (37,398) | — | 
	  
	    | Investment in Via, net of cash acquired | — | (67,835) | — | 
	  
	    | Investment in Wall Street | — | (6,970) | — | 
	  
	    | Investment in YouFirst, net of cash    acquired | — | (9,657) | — | 
	  
	    | Investment in beBetter | — | (1,000) | — | 
	  
	    | Investment in ItzCash, net of cash    acquired | — | (69,301) | — | 
	  
	    | Payment of acquisition earn-out    contingency, Qatarlyst | — | (1,921) | — | 
	  
	    | Investment in Hope Health | — | — | (1,643) | 
	  
	    | Investment in Wdev, net of cash acquired | — | — | (6,320) | 
	  
	    | Investment in EbixHealth JV, net of cash    acquired | — | — | (696) | 
	  
	    | Maturities (purchases) of marketable    securities | (4,087) | 1,201 | (2,115) | 
	  
	    | Capitalized software development costs | (5,745) | (2,805) | (3,988) | 
	  
	    | Capital expenditures | (10,366) | (7,385) | (5,977) | 
	  
	    | Net    cash used in investing activities | (251,590) | (203,071) | (20,739) | 
	  
	    | Cash    flows from financing activities: |  |  |  | 
	  
	    | Proceeds from / (Repayment) to line of    credit, net | 150,008 | 120,500 | (52,436) | 
	  
	    | Proceeds from term loan | 175,500 | 20,000 | 125,000 | 
	  
	    | Principal payments on term loan    obligation | (10,016) | (13,000) | (6,250) | 
	  
	    | Short term loan to a third party | (8,341) | — | — | 
	  
	    | Cash overdraft | (769) | 6,162 | — | 
	  
	    | Repurchase of common stock | (40,820) | (45,732) | (59,784) | 
	  
	    | Payments of long term debt | (80) | — | (600) | 
	  
	    | Payments for capital lease obligations | (6) | (11) | (5) | 
	  
	    | Proceeds from exercise of common stock    options | 439 | 52 | 824 | 
	  
	    | Forfeiture of certain shares to satisfy    exercise costs and the recipients income tax obligations related to stock    options exercised and restricted stock vested | (467) | (398) | (998) | 
	  
	    | Dividends paid | (9,316) | (9,545) | (9,829) | 
	  
	    | Net    cash provided (used) by financing activities | 256,132 | 78,028 | (4,078) | 
	  
	    | Effect of foreign exchange rates on cash    and cash equivalents | $(5,689) | 2,162 | (1,992) | 
	  
	    | Net    change in cash and cash equivalents, and restricted cash | 88,722 | (46,074) | 59,762 | 
	  
	    | Cash and cash equivalents, and    restricted cash at the beginning of the year | $70,867 | 116,941 | 57,179 | 
	  
	    | Cash    and cash equivalents, and restricted cash at the end of the year | $159,589 | 70,867 | 116,941 | 
	  
	    | Supplemental    disclosures of cash flow information: |  |  |  | 
	  
	    | Interest paid | 25,690 | 12,552 | 7,219 | 
	  
	    | Income taxes paid | 10,149 | 10,426 | 16,634 |